Literature DB >> 12943988

Phenotypic changes in MCF-7 cells during prolonged exposure to tamoxifen.

Michael J Fasco1, Agita Amin, Brian T Pentecost, Yi Yang, John F Gierthy.   

Abstract

MCF-7 breast tumor cells form multicellular nodules (foci) over a confluent monolayer in an estradiol (E2)-dependent, antiestrogen-sensitive reaction. A cell line cloned from MCF-7 that displays these phenotypes was probed to determine the effects of long term exposure to tamoxifen on the growth of foci, estrogen receptor alpha (ERalpha) status, and gene responsiveness to E2. In one of two experiments, a heterogeneous cell population emerged (TMX2) that over-expressed estrogen receptor alpha wild type mRNA (ERalpha mRNA) (approximately 20-fold) missing exon 3 (ERDelta3 mRNA) and its corresponding protein (ERDelta3P). On a per mRNA to protein basis, ERDelta3P and wild-type ERalpha were equivalently expressed. Return of the TMX2 population to medium without tamoxifen eventually selected for a population that expressed predominately wild-type ERalpha, whereas TMX2 clones over expressing ERDelta3 mRNA and ERDelta3P retained this phenotype in tamoxifen-free media. In both experiments, expression of all ERalpha mRNAs and proteins declined to barely detectable levels during 6-12 months exposure, concomitant with a progressive increase in the ability of the cells to form foci independently of E2 or tamoxifen. Selection for these various populations suggests that tamoxifen can induce and/or support certain cellular changes that lead to altered ERalpha expression, E2-independent cell growth and resistance to antiestrogens.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12943988     DOI: 10.1016/s0303-7207(03)00256-9

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  15 in total

1.  Expression of the aryl hydrocarbon receptor is not required for the proliferation, migration, invasion, or estrogen-dependent tumorigenesis of MCF-7 breast cancer cells.

Authors:  Barbara C Spink; James A Bennett; Nicole Lostritto; Jacquelyn R Cole; David C Spink
Journal:  Mol Carcinog       Date:  2012-03-02       Impact factor: 4.784

2.  Src tyrosyl phosphorylates cortactin in response to prolactin.

Authors:  Alan Hammer; Sneha Laghate; Maria Diakonova
Journal:  Biochem Biophys Res Commun       Date:  2015-06-01       Impact factor: 3.575

3.  Guanylate-Binding Protein-1 protects ovarian cancer cell lines but not breast cancer cell lines from killing by paclitaxel.

Authors:  Aaron R Tipton; Geoffrey O Nyabuto; Jill A Trendel; Travis M Mazur; John P Wilson; Suzan Wadi; Jacob S Justinger; Garret L Moore; Peter T Nguyen; Deborah J Vestal
Journal:  Biochem Biophys Res Commun       Date:  2016-08-31       Impact factor: 3.575

4.  PAK1 regulates breast cancer cell invasion through secretion of matrix metalloproteinases in response to prolactin and three-dimensional collagen IV.

Authors:  Leah Rider; Peter Oladimeji; Maria Diakonova
Journal:  Mol Endocrinol       Date:  2013-06-06

5.  Inhibition of Neu-induced mammary carcinogenesis in transgenic mice expressing ERΔ3, a dominant negative estrogen receptor α variant.

Authors:  Vicki L Davis; Firdos Shaikh; Katie M Gallagher; Michael Villegas; Sheri L Rea; J Mark Cline; Claude L Hughes
Journal:  Horm Cancer       Date:  2012-09-12       Impact factor: 3.869

6.  Expression of a dominant negative estrogen receptor alpha variant in transgenic mice accelerates uterine cancer induced by the potent estrogen diethylstilbestrol.

Authors:  Vicki L Davis; Retha R Newbold; John F Couse; Sheri L Rea; Katie M Gallagher; Katherine J Hamilton; Eugenia H Goulding; Wendy Jefferson; E M Eddy; Bill C Bullock; Kenneth S Korach
Journal:  Reprod Toxicol       Date:  2012-08-31       Impact factor: 3.143

7.  Synergistic Activation of ERα by Estrogen and Prolactin in Breast Cancer Cells Requires Tyrosyl Phosphorylation of PAK1.

Authors:  Peter Oladimeji; Rebekah Skerl; Courtney Rusch; Maria Diakonova
Journal:  Cancer Res       Date:  2016-03-04       Impact factor: 12.701

8.  Selective Adhesive Cell Capture without Molecular Specificity: New Surfaces Exploiting Nanoscopic Polycationic Features as Discrete Adhesive Units.

Authors:  S Kalasin; E P Browne; K F Arcaro; M M Santore
Journal:  RSC Adv       Date:  2017-02-28       Impact factor: 3.361

9.  Genome-wide reprogramming of the chromatin landscape underlies endocrine therapy resistance in breast cancer.

Authors:  Luca Magnani; Alexander Stoeck; Xiaoyang Zhang; András Lánczky; Anne C Mirabella; Tian-Li Wang; Balázs Gyorffy; Mathieu Lupien
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-01       Impact factor: 11.205

10.  High-density array analysis of DNA methylation in Tamoxifen-resistant breast cancer cell lines.

Authors:  Kristin E Williams; Douglas L Anderton; Maxwell P Lee; Brian T Pentecost; Kathleen F Arcaro
Journal:  Epigenetics       Date:  2013-11-13       Impact factor: 4.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.